The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Design and validation of novel brain-penetrant HCN channel inhibitors to ameliorate social stress-induced susceptible phenotype
Open accessAbstract
Major Depressive Disorder (MDD) is a devastating, multifactorial disease with limited pharmacological treatment options. Patients with MDD exhibit alterations in their dopamine (DA) signaling pathways through the midbrain ventral tegmental area (VTA). A similar observation is also detected in preclinical models of stress - mice exhibit behavioral and physiological impairments following chronic social defeat stress (CSDS). Prior studies demonstrate that CSDS-susceptible mice have increased VTA DA neuronal excitability, in part driven by an upregulation in hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels. Inhibiting HCN channels with known inhibitors such as Cilobradine alleviates the negative behavioral effects of CSDS. Here, we aimed to identify Cilobradine analogs with improved neural tropism and inhibitory efficacy. Two compounds, MS7710 and MS7712 , differing by their left-hand side moieties, have a similar, potent inhibitory effect on VTA DA I h currents as compared to Cilobradine, and a greater inhibitory effect than Cilobradine on VTA DA firing rate. We demonstrate that MS7710 and MS7712 have superior brain/plasma concentration ratios as compared to Cilobradine. They were efficacious at inhibiting VTA DA neuron firing rate and bursting activity in CSDS-susceptible male mice at lower doses than Cilobradine, which was recapitulated in female CSDS-susceptible mice with MS7710 . Finally, we define that a single intraperitoneal injection of MS7710 ameliorates CSDS-induced social interaction deficits and reward-associated cognitive inflexibility for at least two weeks in male and female mice. These findings yield a novel HCN channel inhibitor with improved neural tropism and stress-alleviating effects that could provide a basis for future antidepressant drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“By contrast, antagonizing HCN channels in ventral tegmental dopamine neurons or blocking HCN in basolateral amygdala prolongs inhibition and heightens anxiety, cautioning against indiscriminate blockade [283,288].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [283]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In post-stroke mice, hippocampal HCN1 inhibition lowers Ih, suppresses NOD-, LRR-, and pyrin domain–containing protein 3 (NLRP3) signaling, and ameliorates depression- and anxiety-like phenotypes; chronic hippocampal cAMP elevation similarly reduces HCN surface expression and rescues stress-induced cognitive deficits, consistent with a network shift away from internally oriented attractor states [”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [283]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Across preclinical systems, convergent evidence indicates that tempering Ih via partial HCN downregulation can normalize large-scale dynamics associated with perseverative self-focus [282,283,284].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [283]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In post-stroke mice, hippocampal HCN1 inhibition lowers Ih, suppresses NOD-, LRR-, and pyrin domain–containing protein 3 (NLRP3) signaling, and ameliorates depression- and anxiety-like phenotypes; chronic hippocampal cAMP elevation similarly reduces HCN surface expression and rescues stress-induced cognitive deficits, consistent with a network shift away from internally oriented attractor states [”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [283]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A brain-penetrant HCN blocker produces antidepressant-like effects, supporting target validity while underscoring the need for dose-limited, partial modulation [283,288].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [283]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 1×
“Yet the majority of MDD patients do not respond adequately to their fi rst antidepressant, and approximately one-third remain unresponsive to current antidepressants and are considered treatment-resistant [11].”
Dopamine in motivational control: rewarding, aversive, and alerting
Bromberg-Martin, E. S., Matsumoto, M., & Hikosaka, O. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.022 · Cited by 2,396
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307
Self-citationWhy is depression more common among women than among men?
Kuehner, C. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30263-2 · Cited by 1,752
A standardized protocol for repeated social defeat stress in mice
Golden, S. A., Covington, H. E., Berton, O., & Russo, S. J. (2011) · Nature Protocols · doi:10.1038/nprot.2011.361 · Cited by 1,581 · cited 2×
“The CSDS paradigm was performed as previously established [47, 48].”
Self-citationDavid, D. J., Samuels, B. A., Rainer, Q., Wang, J.-W., Marsteller, D., Mendez, I., Drew, M., Craig, D. A., Guiard, B. P., Guilloux, J.-P., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.04.017 · Cited by 1,267
Self-citationRapid regulation of depression-related behaviours by control of midbrain dopamine neurons
Chaudhury, D., Walsh, J. J., Friedman, A. K., Juarez, B., Ku, S. M., Koo, J. W., Ferguson, D., Tsai, H.-C., Pomeranz, L., Christoffel, D. J., et al. (2013) · Nature · doi:10.1038/nature11713 · Cited by 1,156
Self-citationFloresco, S. B., West, A. R., Ash, B., Moore, H., & Grace, A. A. (2003) · Nature Neuroscience · doi:10.1038/nn1103 · Cited by 1,106
Wager, T. T., Hou, X., Verhoest, P. R., & Villalobos, A. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100008c · Cited by 1,063 · cited 2×
“Cilobradine ’ s analogs exhibited a variety of effects; 11 demonstrated less than half the ef fi cacy of Cilobradine, while 6, 4 , and 3 improved upon 11 ’ s ef fi cacy but were less ef fi cacious than Cilobradine.”
Dopamine reward prediction-error signalling: A two-component response
Schultz, W. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.26 · Cited by 1,036
Research works printed but not linked: 2
- Friedrich MJ. Depression Is the leading cause of disability around the world. JAMA. 2017;317:1517.
- Savelieva I, Camm AJ. Novel if current inhibitor ivabradine: safety considerations. Heart Rate Slowing Curr Inhibition. 2006;43:79–96.
Cited by
Sex‐Specific Adaptations to VTA Circuits Following Subchronic Stress
Bouarab, C., Wynalda, M., Thompson, B. V., Khurana, A., Cody, C. R., Kisner, A., & Polter, A. M. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70153 · Cited by 18
“…results suggest potential synaptic mechanisms for regulation of VTA dopaminergic firing following SCVS, stress-linked alterations in dopaminergic firing can also be linked to intrinsic mechanisms such as changes in HCN channels (Cao et al. 2010; Zhong et al. 2017; Teichman et al. 2025).”
Margolis, E. B. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.09.669424 · Cited by 3
Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Kim, C. S., Kim, J., & Michael, S. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03871-4 · Cited by 1
“…linked to a range of stress-related outcomes in other rodent models, including chronic unpredictable stress and chronic social defeat stress [16 – 19], where they in fl uence neuronal excitability, key molecular markers including brain-derived neurotrophic factor and mammalian target of…”
Channel Dysfunction as the Basis for Comorbidities in Multiple Sclerosis and Depression
Rychlik, N., Jüngling, K., Meuth, S. G., Budde, T., & Méndez‐Couz, M. (2026) · Archiv der Pharmazie · doi:10.1002/ardp.70273 · Cited by 1
Metadata
- Authors
- Teichman, E. M., Hu, J., Lin, H.-Y., Fisher-Foye, R. L., Blando, A., Hu, X., Kaniskan, H. Ü., Montgomery, S. E., Cai, M., Parise, L. F., Wang, J., Russo, S. J., Han, M.-H., Jin, J., & Morel, C.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- James J. Peters VA Medical Center (US)
- Chinese Academy of Sciences (CN)
- Tisch Cancer Institute (US)
- Corresponding author
- Han, Ming-Hu
- Jin, Jian
- Morel, Carole
- ORCID
- Venue
- Molecular Psychiatry
- Published
- 2025-04-08
- Volume
- 30
- Issue
- 9
- Pages
- 3937-3950
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC12339378
- OpenAlex
- W4409256954
- Cited by
- 5
- References
- 86
- Citations by year
- 2026: 3 · 2025: 2
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Molecular Psychiatry (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH120637, R01MH120514, F31MH131358, R01MH133299, R01MH104559, R01MH127820)
- U.S. Department of Veterans Affairs (I01BX005722)
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (1S10OD025132, 1S10OD028504)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- major depressive disorder, chronic social defeat stress, ventral tegmental area, brain penetration, social interaction deficits, cognitive inflexibility, antidepressant drug discovery, sex differences
- MeSH terms
- Social Defeat, Animals, Brain, Major Depressive Disorder, Disease Models, Animal, Dopamine, Male, Mice, Inbred C57BL, Phenotype, Stress, Psychological, Ventral Tegmental Area, Mice, Dopaminergic Neurons, Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Design and validation of novel brain-penetrant HCN channel inhibitors to ameliorate social stress-induced susceptible phenotype. https://app.cochat.ai/papers/10.1038/s41380-025-02972-8
- The paper
- Teichman, E. M., Hu, J., Lin, H.-Y., Fisher-Foye, R. L., Blando, A., Hu, X., Kaniskan, H. Ü., Montgomery, S. E., Cai, M., Parise, L. F., Wang, J., Russo, S. J., Han, M.-H., Jin, J., & Morel, C. (2025). Design and validation of novel brain-penetrant HCN channel inhibitors to ameliorate social stress-induced susceptible phenotype. Molecular Psychiatry. https://doi.org/10.1038/s41380-025-02972-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.